Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Opioid Abuse: White House Expanding Access To Buprenorphine, Naloxone

This article was originally published in The Pink Sheet Daily

Executive Summary

HHS is issuing a proposed rule to increase buprenorphine prescription limit and providing $11m in new funding to states for training and purchase of opioid overdose drug naloxone.


Related Content

FDA’s Naloxone Product Approval Standards May See Changes
Bring Naloxone To Opioid Overdoses: FDA Crowd-Sources Smartphone Apps
Naloxone Costs Could Temper Non-Rx Access Even As Distribution Spreads





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts